References
- Raajimakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schröder FH. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002;60:826–30.
- Berger AP, Gozzi C, Steiner H, Frauscher F, Varkarakis J, Rogatsch H, Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. J Urol 2004;171:1478–80.
- Djavan B, Waldert M, Zlotta A, Dobronski P, Seitz C, Remzi M, Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol 2001;166:856–60.
- Nam RK, Saskin R, Lee Y, Liu Y, Law C, Klotz LH, Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010;183:963–8.
- Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998;52:552–8.
- Aus G, Hermansson CG, Hugosson J, Pedersen KV. Transrectal ultrasound examination of the prostate: complications and acceptance by patients. Br J Urol 1993;71:457–9.
- Fong IW, Struthers N, Honey RJ, Simbul M, Boisseau DA. A randomised comparative study of the prophylactic use of trimethoprim–sulfamethoxazole versus netilmycin–metronidazol in transrectal prostatic biopsy. J Urol 1991;146:794–7.
- Griffith BC, Morey AF, Ali-Khan MM, Canby-Hagino E, Foley JP, Rozanski TA. Single dose Levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol 2002;168:1021–3.
- Lindstedt S, Lindström U, Ljunggren E, Wullt B, Grabe M. Single-dose antibiotic prophylaxis in core prostate biopsy: impact of timing and identification of risk factors. Eur Urol 2006;50:832–7.
- Bootsma AM, Laguna Pes MP, Geerlings SE, Goossens A. Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol 2008;54:1270–86.
- Enlund AL, Varenhorst E. Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases. Br J Urol 1997;79:777–80.
- Aspevall O, Hallander H. Referensmetodik för laboratoriediagnostik vid kliniskt bakteriologiska laboratorier. I5. Urinvägsinfektioner/bakteriuri Svenska läkaresällskapets section för medicinsk mikrobiologi i samverkan med Smittskyddsinstitutet, 2:a upplagan; 2000.
- Murray PR. Manual of clinical microbiology. Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. 7th ed. Washington, DC: ASM Press; 1999.
- Brönnestam R. Direct antimicrobial susceptibility testing in bacteriuria. APMIS 1999;107:437–44.
- Ringertz S, Olsson-Liljequist B, Kahlmeter G, Kronvall G. Antimicrobial susceptibility testing in Sweden. II. Species-related zone diameter breakpoints to avoid interpretive errors and guard against unrecognized evolution of resistance. Scand J Infect Dis Suppl 1997;105:8–12.
- Sieber PR, Rommel FM, Theodoran CG, Hong RD, Del Terzo MA. Contemporary prostate biopsy complication rates in community-based urology practice. Urology 2007;70:498–500.